Public-private partnerships in personalised medicine

Changing dynamics of elderly myeloma patients

International Myeloma Workshop 2011 round up

Tackling cancer in China

Treatment of multiple myeloma at the Dana Faber Institute

Multiple Myeloma in the non-transplant setting (1/2)

Multiple Myeloma in the transplant setting (2/2)

Techniques to assess response to treatment and the management of bone disease in myeloma

Disease staging in myeloma and the implications for therapy

Flexible dosing of bortezomib for multiple myeloma

Lenalidomide and dexamethasone to delay progression of smouldering multiple myeloma

International Myeloma Workshop highlights and ongoing IMF studies